Israel Journal of Psychiatry and Related Sciences最新文献_第8页

Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome. 美沙酮维持治疗患者19.5年苯二氮卓的使用及其与远期预后的关系。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Einat Peles, Miriam Adelson, Shaul Schreiber

{"title":"Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome.","authors":"Einat Peles, Miriam Adelson, Shaul Schreiber","doi":"","DOIUrl":"","url":null,"abstract":"Background: Benzodiazepines (BDZs) abuse was found to cause diverse harmful effects among MMT patients. The current study evaluates prevalence rates of BDZ usage during 19.5 years in MMT, and its relation to patients' long-term retention in treatment.Methods: All 787 opiate addicts who were ever admitted to the Adelson MMT clinic in Tel Aviv between 1993 and 2012 were studied. Observed and random urine results for BDZs usage were taken a few times every month. Positive for BDZ was defined in each month if at least one of the urines tested positive. Long-term retention was studied using Kaplan Meier analyses.Results: BDZ prevalence among the MMT patients (ranged from 26 patients in 1994, and 300 to 350 since 2009) was about 35-40% in the last few years, with a \"peak\" of 61% followed by low rate of 25.4%. Followed up for up to 19.5 years, those who were negative to BDZ upon admission to MMT stayed longer in treatment (mean 8.5y, 95% Confidence Interval [CI] 7.6-9.4) than those who were positive to BDZ when admitted (mean 6.9y, 95% CI 6.2-7.7) (Kaplan Meier analyses p=0.01).Conclusion: BDZs abuse is highly prevalent among MMT patients. Abuse of BDZ on entry to treatment predicts worse MMT outcome. High and low rates of BDZ abuse may also be attributed to staff tolerance of this abuse; thus, we strongly recommend a strict attitude by staff in order to reduce patients' harm.","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"51 4","pages":"285-8"},"PeriodicalIF":0.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33187510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mentalization-based treatment for psychosis: linking an attachment-based model to the psychotherapy for impaired mental state understanding in people with psychotic disorders. 以精神化为基础的精神病治疗:将依恋为基础的模型与精神障碍患者精神状态理解受损的心理治疗联系起来。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Benjamin K Brent, Daphne J Holt, Matcheri S Keshavan, Larry J Seidman, Peter Fonagy

引用次数: 0

Ethics and the psychiatry journal editor: responsibilities and dilemmas. 伦理与精神病学期刊编辑:责任与困境。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

David Greenberg, Rael D Strous

引用次数: 0

Metacognition in schizophrenia: a concept coming of age. 精神分裂症的元认知:一个成熟的概念。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Martin Brüne

引用次数: 0

Gender differences in the prevalence and correlates of psychotropic medication use among older adults in Israel. 以色列老年人精神药物使用的患病率及相关因素的性别差异

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Tzvia Blumstein, Yael Benyamini, Dov Shmotkin, Liat Lerner-Geva

{"title":"Gender differences in the prevalence and correlates of psychotropic medication use among older adults in Israel.","authors":"Tzvia Blumstein, Yael Benyamini, Dov Shmotkin, Liat Lerner-Geva","doi":"","DOIUrl":"","url":null,"abstract":"Background: This study evaluates gender differences in the prevalence of psychotropic medications use among elderly Israelis and the socio-demographic, physical and mental health correlates of their use.Method: Data were taken from a national survey that sampled the community-dwelling Jewish population aged 65-94 in Israel. Psychotropic medications were assessed from the list of all medications recorded during a faceto- face interview. The current analysis focused on three medication groups: anxiolytics, sedatives/hypnotics and antidepressants.Results: A significantly higher use of anxiolytics was observed among women compared to men after taking into account their worse physical and mental health. Age, not being married, sleeping problems and depressive symptoms were significant correlates among men while number of non-psychotropic medications, any life trauma and being married correlated with use of anxiolytics and sedatives/hypnotics among women. The use of antidepressants was low in men and women and was related mainly to disability in ADL.Conclusions: This study points to possibly overprescribing of anxiolytics among women and low detection and treatment of depression among the elderly in general.","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"51 2","pages":"118-25"},"PeriodicalIF":0.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32795538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Emerging issues in the relationship between adolescent substance use and suicidal behavior. 青少年药物使用与自杀行为之间关系的新问题。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Dan Shlosberg, Gil Zalsman, Gal Shoval

引用次数: 0

Flashbacks and HPPD: A Clinical-oriented Concise Review. 闪回和HPPD:临床导向的简明综述。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Arturo G Lerner, Dmitri Rudinski, Oren Bor, Craig Goodman

{"title":"Flashbacks and HPPD: A Clinical-oriented Concise Review.","authors":"Arturo G Lerner, Dmitri Rudinski, Oren Bor, Craig Goodman","doi":"","DOIUrl":"","url":null,"abstract":"A unique characteristic of LSD, LSD-like and substances with hallucinogenic properties is the recurrence of some or all the hallucinogenic symptoms which had appeared during the intoxication after the immediate effects of the substance had worn off. This recurring syndrome, mainly visual, is not clearly understood. The terms Flashback and Hallucinogen Persisting Perception Disorder (HPPD) have been used interchangeably in the professional literature. We have observed at least two different recurrent syndromes, the first Flashback Type we refer to as HPPD I, a generally short-term, non-distressing, benign and reversible state accompanied by a pleasant affect. In contrast, the second HPPD Type we refer to as HPPD II, a generally long-term, distressing, pervasive, either slowly reversible or irreversible, non-benign state accompanied by an unpleasant affect. HPPD I and II appear to be part of a broad spectrum of non-psychopathological and psychopathological states reported by hallucinogen users. HPPD I and II may be clinically characterized by prodromal symptoms, onset, content of visual imagery, precipitators, frequency, duration and intensity of perceptual recurrences, severity, course, differential diagnosis, accompanying mood and affect, insight and remission. Pharmacological therapy with or without preceding or following co-occurring psychiatric disorders have been shown to ameliorate this syndrome. A large variety of medications may be utilized to alleviate this condition, but with differential results suggesting several subtypes. The purpose of this manuscript is to provide a clinical-oriented, comprehensive and concise review to treating psychiatrists. ","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"51 4","pages":"296-301"},"PeriodicalIF":0.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33188518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Examining the ethical boundaries of harm reduction: from addictions to general psychiatry. 检查减少伤害的伦理界限:从成瘾到普通精神病学。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Shaul Lev-Ran, Uri Nitzan, Shmuel Fennig

引用次数: 0

Patient suicide. 病人自杀。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

David Greenberg, Gabi Shefler

引用次数: 0

Metacognitive change as a predictor of outcome in cognitive therapy for psychosis. 元认知改变作为精神病认知治疗结果的预测因子。

IF 0.4 4区医学

Israel Journal of Psychiatry and Related Sciences Pub Date : 2014-01-01

Sophie Parker, Adrian Wells, Anthony P Morrison

{"title":"Metacognitive change as a predictor of outcome in cognitive therapy for psychosis.","authors":"Sophie Parker, Adrian Wells, Anthony P Morrison","doi":"","DOIUrl":"","url":null,"abstract":"Background: There is little known about predictors of response to cognitive therapy (CT) for psychosis. This study tests the hypothesis that metacognitive change at both end of treatment and follow-up is associated with positive outcomes in people with psychosis receiving CT.Method: Patients referred for CT for psychosis were offered CT over a maximum of 30 sessions. Assessments, including interview-based measures of psychotic symptoms and a questionnaire assessing metacognitive worry, were performed at pre-CT, post-CT and one-year follow-up. Data from 32 patients were analyzed.Results: Significant positive relationships were found between metacognitive worry change scores at one-year follow-up and both positive symptoms of psychosis and particular dimensions of hallucinations. No significant relationships were found between metacognitive change and delusional symptoms.Conclusions: These results suggest that metacognitive change is associated with symptom change at followup. In particular, these benefits seem most evident in those people experiencing hallucinations. Methodological limitations and clinical implications are discussed.","PeriodicalId":49288,"journal":{"name":"Israel Journal of Psychiatry and Related Sciences","volume":"51 1","pages":"8-16"},"PeriodicalIF":0.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32365557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0